Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-12 08:14 am Purchase |
2020-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
AVORO CAPITAL ADVISORS LLC | 3,232,142 9.090% |
3,232,142 (New Position) |
Filing History |
| 2021-02-12 08:14 am Purchase |
2020-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE |
AVORO CAPITAL ADVISORS LLC | 2,800,000 8.000% |
400,000 (+16.67%) |
Filing History |
| 2021-02-12 08:13 am Sale |
2020-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
AVORO CAPITAL ADVISORS LLC | 0 0.000% |
-393,333 (Position Closed) |
Filing History |
| 2021-02-12 08:13 am Sale |
2020-12-31 | 13G | Cue Biopharma, Inc. CUE |
AVORO CAPITAL ADVISORS LLC | 452,500 1.500% |
-1,417,500 (-75.80%) |
Filing History |
| 2021-02-12 08:12 am Sale |
2020-12-31 | 13G | Athenex, Inc. ATNX |
AVORO CAPITAL ADVISORS LLC | 18,625 0.400% |
-244,447 (-92.92%) |
Filing History |
| 2021-02-12 08:11 am Sale |
2020-12-31 | 13G | Alimera Sciences, Inc. ALIM |
AVORO CAPITAL ADVISORS LLC | 0 0.000% |
-415,999 (Position Closed) |
Filing History |
| 2021-02-12 08:11 am Purchase |
2020-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
AVORO CAPITAL ADVISORS LLC | 2,350,267 5.300% |
2,350,267 (New Position) |
Filing History |
| 2021-02-12 08:10 am Purchase |
2020-12-31 | 13G | Therapeutics Acquisition Corp. RACA |
AVORO CAPITAL ADVISORS LLC | 1,000,000 7.100% |
1,000,000 (New Position) |
Filing History |
| 2021-02-12 08:09 am Purchase |
2020-12-31 | 13G | Trillium Therapeutics Inc. TRIL |
AVORO CAPITAL ADVISORS LLC | 5,800,000 5.700% |
5,800,000 (New Position) |
Filing History |
| 2021-02-12 08:09 am Purchase |
2020-12-31 | 13G | Kura Oncology, Inc. KURA |
AVORO CAPITAL ADVISORS LLC | 4,000,000 6.200% |
4,000,000 (New Position) |
Filing History |
| 2021-02-12 08:08 am Purchase |
2020-12-31 | 13G | United Therapeutics Corporation UTHR |
AVORO CAPITAL ADVISORS LLC | 2,850,000 6.400% |
2,850,000 (New Position) |
Filing History |
| 2021-02-12 08:08 am Purchase |
2020-12-31 | 13G | Arena Pharmaceuticals, Inc. ARNA |
AVORO CAPITAL ADVISORS LLC | 4,190,000 7.200% |
4,190,000 (New Position) |
Filing History |
| 2021-02-12 08:07 am Purchase |
2020-12-31 | 13G | Avadel Pharmaceuticals plc AVDL |
AVORO CAPITAL ADVISORS LLC | 4,365,000 7.500% |
4,365,000 (New Position) |
Filing History |
| 2021-02-12 08:06 am Purchase |
2020-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
AVORO CAPITAL ADVISORS LLC | 1,225,000 7.900% |
1,225,000 (New Position) |
Filing History |
| 2021-02-12 08:06 am Purchase |
2020-12-31 | 13G | IVERIC bio, Inc. ISEE |
AVORO CAPITAL ADVISORS LLC | 7,250,000 8.100% |
7,250,000 (New Position) |
Filing History |
| 2021-02-12 08:05 am Purchase |
2020-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
AVORO CAPITAL ADVISORS LLC | 1,525,000 9.400% |
1,525,000 (New Position) |
Filing History |
| 2021-02-12 08:04 am Purchase |
2020-12-31 | 13G | Mersana Therapeutics, Inc. MRSN |
AVORO CAPITAL ADVISORS LLC | 6,800,000 9.900% |
6,800,000 (New Position) |
Filing History |
| 2021-02-12 08:04 am Purchase |
2020-12-31 | 13G | Genocea Biosciences, Inc. GNCA |
AVORO CAPITAL ADVISORS LLC | 33,613,444 9.990% |
33,613,444 (New Position) |
Filing History |
| 2021-02-12 08:03 am Sale |
2020-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA |
AVORO CAPITAL ADVISORS LLC | 7,500,000 5.100% |
-1,326,039 (-15.02%) |
Filing History |
| 2021-02-12 08:01 am Sale |
2020-12-31 | 13G | Constellation Pharmaceuticals, Inc. CNST |
AVORO CAPITAL ADVISORS LLC | 2,950,000 6.200% |
-700,000 (-19.18%) |
Filing History |